Φορτώνει......
Belimumab in Systemic Lupus Erythematosus
Belimumab is the only approved biological agent for the treatment of systemic lupus erythematosus (SLE). It is a fully humanized IgG1γ monoclonal antibody directed against soluble B lymphocyte stimulator (BLyS). It is indicated as an add-on therapy for the treatment of adult patients with active, au...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Indian J Dermatol |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Medknow Publications & Media Pvt Ltd
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5029243/ https://ncbi.nlm.nih.gov/pubmed/27688447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.190107 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|